MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Development and Validation of a Clinical Scale for Distinguishing Multiple System Atrophy from 4-Repeat Tauopathies

    I. Ruiz Barrio, A. Horta Barba, A. Puig Davi, I. Aracil Bolaños, A. Quattrone, S. Martinez Horta, J. Kulisevksy, J. Pagonabarraga (Barcelona, Spain)

    Objective: We aimed to develop a clinical scale that distinguishes between Multiple System Atrophy (MSA) and 4-repeat tauopathies (4RT: CBD, PSP) using a standardized neurological…
  • 2024 International Congress

    Frequency of Falls as a Presenti̇ng Symptom and Its Effect i̇n Prognosi̇s i̇n Progressi̇ve Supranuclear Palsy

    I. Kamacı, B. Marangozoglu Samanci, B. Zorlu Ucuncuoglu, E. Sahin, B. Bilgin, H. Hanağası (Istanbul, Turkey)

    Objective: We aimed to evaluate frequency of falls as a presenting symptom and its effect on prognosis in PSP patients. Background: Progressive supranuclear palsy is…
  • 2024 International Congress

    Unveiling the Link: Insulin’s Novel Role in Modulating α-Synuclein Accumulation in Parkinson’s Disease

    Y. Wu (München, Germany)

    Objective: This study marks the inaugural attempt to investigate the direct effects of insulin on pathological α-synuclein accumulation induced by the addition of α-synuclein preformed…
  • 2024 International Congress

    Utilization of Skin Punch Biopsy for the Diagnosis of Alpha-synucleinopathy in Clinical Practice

    C. Gummerson, S. Tinaz, V. Santini, A. Zubair (New Haven, USA)

    Objective: To understand the use of skin punch biopsies for diagnosis and management of α-synucleinopathy within a large medical system. Background: Skin punch biopsy has…
  • 2024 International Congress

    Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study

    N. Bohnen, G. Carli, F. Michalakis, C. Pongmala, M. Emde Boas, R. Albin, P. Kanel (Ann Arbor, USA)

    Objective: To explore the role of cholinergic dysfunction in dyskinesia symptoms in people with Parkinson’s disease (PD). Background: Dyskinesias, involuntary and sometimes excessive or uncontrolled…
  • 2024 International Congress

    Clinical Profile of Motor Complications in Parkinson’s Disease Patients at A National Tertiary Hospital In Indonesia

    Y. Rapri, A. Jody, A. Tiksnadi, D. Tunjungsari (Depok, Indonesia)

    Objective: To analyse factors associated with motor complications in Parkinson's disease at a national tertiary referral hospital in Indonesia. Background: As Parkinson's disease progresses, levodopa…
  • 2024 International Congress

    Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?

    A. Martinez Nunez, N. Walker-Pizarro, A. Wagle Shukla, A. Ramirez-Zamora, N. Mcfarland (Gainesvile, USA)

    Objective: To examine the utility of commercially available skin phosphorylated alpha-synuclein deposition test (pSyn) in patients with clinically ambiguous parkinsonism and its concordance with dopamine…
  • 2024 International Congress

    The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

    S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the difficulties faced by very late-onset patients with Parkinson’s disease (PD), caregivers and attending physicians, and…
  • 2024 International Congress

    Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder

    A. Falcone, I. Brum, F. Freua, E. Barbosa, R. Cury, J. Parmera (Sao Paulo, Brazil)

    Objective: To describe a stepwise evaluation of a patient with a secondary parkinsonism that mimic idiopathic Parkinson´s Disease (PD). Background: PD clinically established encompasses the…
  • 2024 International Congress

    Eye movements and cognitive function

    A. Ovchynnykova, Y. Trufanov, M. Trishchynska (Kyiv, Ukraine)

    Objective: find out the relationship between eye movements and cognitive function (CF). Background: working in our clinic we have learned to give a pre-assessment of…
  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley